Getting drugs and devices to the doorstep is only half the battle. When digital connections fail, trials fail. Why the digital last mile needs clinical supply ownership, human-centered design, and tech support with a bedside manner.
- The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- Accelerating Clinical Innovation With Open-Source Medical Platforms
- From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
- How To Identify Patient-Centric Risks In The TMF With AI And Automation
- How The TMF Demonstrates Patient Safety And Rights In DCTs
- Begin Your AI-Led Digital Clinical Transformation With A Phased Approach
- How AI Is Rewriting The Future Of TMF And Clinical Quality
ON-DEMAND WEBINARS
Chief Scientific Officer Christine Guo, Ph.D., provides key insights into DHTs aimed at empowering study teams to strategically integrate these technologies into their clinical development initiatives.
With so many moving parts in a clinical trial, why worry about the technology that is supposed to help manage it? In this webinar, explore five actionable and necessary strategies to leverage RTSM to simplify clinical trial operations.
AI has great potential to enhance the efforts of your team members by accelerating data interactions. Watch this webinar and discover how AI can improve clinical trial outcomes and data management.
Explore the transformative impact of flexible ePRO technology on clinical trials, elucidating how it enhances patient-centricity and operational efficiency for sponsors.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![Emotions-iStock-471812192]( "The Case For Cognitive Assessments In Phase 1 Clinical Trials")
The Case For Cognitive Assessments In Phase 1 Clinical TrialsRegulators prioritize patient-reported outcomes. Cognitive assessments in Phase 1 trials detect early drug-related cognitive effects, ensuring safety and efficacy. Signant’s CDR System® is a proven tool for this.
-
![Scientists Examining Data GettyImages-1346675624]( "How Paper And Electronic Source Data Meet ALCOA-C Principles")
How Paper And Electronic Source Data Meet ALCOA-C PrinciplesAccording to the Food and Drug Administration (FDA), data should meet certain fundamental elements of quality. If these best practices for source documentation aren’t followed, there is no valid evidence the test article is safe and effective.
-
![GettyImages-1452403953-patient-recruitment-selection]( "Reframing Vendor Selection: Beyond Price And Past Relationships")
Reframing Vendor Selection: Beyond Price And Past RelationshipsAn RFP is more than a budget tool — it’s a strategic communication document that guides vendors, clarifies expectations, and enables informed, data-driven sponsor decisions.
-
![Performance GettyImages-579421538]( "Clinical Trial Governance A Strategic Look At KPIs From An RTSM Perspective")
Clinical Trial Governance A Strategic Look At KPIs From An RTSM PerspectiveLearn how data-driven metrics improve oversight, mitigate risk, and accelerate execution while safeguarding supply continuity and patient safety.
-
![GettyImages-1159575307 econsent]( "A Better Approach To eConsent: Flexibility With Enabled Technology")
A Better Approach To eConsent: Flexibility With Enabled TechnologyElectronic consent, or eConsent, digitalizes the trial participant consent process through increasingly simplified, interactive, educational models designed to improve comprehension and boost engagement.
-
![GettyImages-576919878-analytics-computer-testing-research-data]( "EDC Powers End-To-End Data Management In Pharma-Sponsored Trials")
EDC Powers End-To-End Data Management In Pharma-Sponsored TrialsAs clinical research moves toward adaptive, decentralized, and data-rich models, EDC remains the backbone that makes innovation operationally feasible.
-
![Doctor-patient-GettyImages-1345513639]( "Balancing Clinical Care With Digital Utility In Hybrid Trials")
Balancing Clinical Care With Digital Utility In Hybrid TrialsTo create an effective decentralized clinical trial, tools and methods must be considered within the context of challenges faced by the clinical trial’s patients, physicians, and sites.
-
![GettyImages-1947164077 ALS]( "Advancing ALS Research With Digital Health Technologies")
Advancing ALS Research With Digital Health TechnologiesExplore how wearable, sensor-based digital health technologies can revolutionize ALS patient monitoring by reading our latest insights from the Digital Health Monthly scientific webinar series.
-
![GettyImages-1403976499 vaccine, development]( "Accelerated Approval As The New \"Norm\" In Gene Therapy For Rare Diseases")
Accelerated Approval As The New "Norm" In Gene Therapy For Rare DiseasesGene therapy has revolutionized treatment prospects for rare genetic disorders by enabling corrective or replacement strategies at the molecular level.
-
![Online virtual doctor telehealth iStock-1001338258]( "Televisits In Clinical Trials: Why Integrate A Telemedicine Feature In Your eCOA Trials?")
Televisits In Clinical Trials: Why Integrate A Telemedicine Feature In Your eCOA Trials?If remote visits are planned in both decentralized and hybrid trials, how precisely do the televisits work and how beneficial can this really be to study patients, site staff, and sponsors?
